Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Cameron

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 10, 2024
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLCJacobi B Hines, Robert B Cameron, Alessandra Esposito, et al.
The Lancet. Oncology|May 19, 2022
EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 studyMarjorie G Zauderer, Peter W Szlosarek, Sylvestre Le Moulec, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 15, 2024
Going to MARS may shorten our patient's survivalR Taylor Ripley, Prasad S Adusumilli, Adam J Bograd, et al.
Cancer Discovery|February 17, 2025
High Glucose Contribution to the TCA Cycle Is a Feature of Aggressive Non-Small Cell Lung Cancer in PatientsLing Cai, Nia G Hammond, Alpaslan Tasdogan, et al.
International Journal of Occupational and Environmental Health|May 15, 2010
Scientists appeal to Quebec Premier Charest to stop exporting asbestos to the developing worldTim K Takaro, Devra Davis, Sue Janse Van Rensburg, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 10, 2024
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLCJacobi B Hines, Robert B Cameron, Alessandra Esposito, et al.
The Lancet. Oncology|May 19, 2022
EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 studyMarjorie G Zauderer, Peter W Szlosarek, Sylvestre Le Moulec, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 15, 2024
Going to MARS may shorten our patient's survivalR Taylor Ripley, Prasad S Adusumilli, Adam J Bograd, et al.
Cancer Discovery|February 17, 2025
High Glucose Contribution to the TCA Cycle Is a Feature of Aggressive Non-Small Cell Lung Cancer in PatientsLing Cai, Nia G Hammond, Alpaslan Tasdogan, et al.
International Journal of Occupational and Environmental Health|May 15, 2010
Scientists appeal to Quebec Premier Charest to stop exporting asbestos to the developing worldTim K Takaro, Devra Davis, Sue Janse Van Rensburg, et al.
Pageof 9